SecBot SecBot
SECBOTREPLAY Home › Report › PTGX

PTGX · CEO Dinesh Patel filed a Form 144 to sell 75,000 shares (~$7.76M at the…

Protagonist Therapeutics, Inc · 144 filed May 12, 2026 at 17:29 ET

At the news

BEARISHIMPACT 5/10

144 filed May 12, 2026 at 17:29 ET

CEO Dinesh Patel filed a Form 144 to sell 75,000 shares (~$7.76M at the filing date) via J.P. Morgan. This is a material insider sale by the CEO, representing about 1.2% of his known holdings and 0.1% of market cap. The sale follows an option exercise and comes amid strong analyst consensus (89% bullish) and a $6.7B market cap.

  • CEO Dinesh Patel filed Form 144 to sell 75,000 shares of common stock.
  • Approximate dollar value of proposed sale: $7,762,500.
  • Shares to be sold via J.P. Morgan Securities LLC.
  • Patel's total beneficial ownership after sale: ~64,311,373 shares.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access